Skip to main content
logo
Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
0.6076
-0.0171 (-2.74%)
Jul 28, 2026, 11:52 AM EDT - Market open

Aprea Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.120.291.50.58--
Revenue Growth
-90.40%-80.98%157.63%---
Gross Profit
0.120.291.50.58--
Selling, General & Admin
6.536.486.468.4320.9713.55
Research & Development
6.177.049.367.6392.4223.9
Total Operating Expenses
12.713.5215.8216.06113.3937.45
Operating Income
-12.58-13.23-14.32-15.47-113.39-37.45
Other Non-Operating Income (Expense)
-0.08----
Total Non-Operating Income (Expense)
0.620.631.361.190.730.32
Pretax Income
-11.95-12.6-12.96-14.29-112.66-37.13
Net Income
-11.95-12.6-12.96-14.29-112.66-37.13
Net Income to Common
-11.95-12.6-12.96-14.29-112.66-37.13
Net Income Growth
------
Shares Outstanding (Basic)
976421
Shares Outstanding (Diluted)
976421
Shares Change
46.19%18.67%52.31%118.31%55.69%0.72%
EPS (Basic)
-1.54-1.93-2.35-3.95-67.99-34.88
EPS (Diluted)
-1.54-1.93-2.35-3.95-67.99-34.88
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-12.02-12.89-13.57-12.27-25.01-37.69
Free Cash Flow Growth
------
Free Cash Flow Per Share
-1.38-1.97-2.46-3.39-15.09-35.41
Gross Margin
100.00%100.00%100.00%100.00%--
Operating Margin
-10202.00%-4631.12%-953.00%-2652.80%--
Profit Margin
-9696.04%-4409.16%-862.43%-2449.59%--
FCF Margin
-9748.90%-4512.35%-903.26%-2103.92%--
EBITDA
-12.56-13.21-14.3-15.46-113.21-37.17
EBITDA Margin
-10184.40%-4623.52%-951.52%-2651.59%--
EBIT
-12.58-13.23-14.32-15.47-113.39-37.45
EBIT Margin
-10202.00%-4631.12%-953.00%-2652.80%--
SEC Filings: 10-K · 10-Q